- Enabling Economic Recovery Through Innovation
- The Top 12 Science Progress Features of 2008
- Breaking: Physicist John Holdren Is Likely Pick for Science Advisor
- Looking for a Research Bailout
- Want to Work Together? The Impact of Multi-University Collabortion
- “The Single Most Effective Way to Prevent the Transmission of Disease”
- Chu Is Bringing Science Back
- National Research Council: Nanotech Safety Needs a Closer Look. Much Closer.
- Neuroscience Everywhere
- Change for America on Science and Tech Policy, Part 4: The Office of Science and Technology Policy
- CNN Decides It Can Cover Science Without Dedicated Science Reporters
- Stem Cell Recommendations for the New Administration
Embryonic Stem Cells As Anti-cancer Labs
Amid the premature hype about induced pluripotent stem cells (hyped by everyone but the scientists who did the work themselves), the unique characteristics of embryonic stem cells as platforms for learning about human disease can too easily be lost. An important new study should help correct this oversight.
A distinguished team of Northwestern University researchers has found that a gene called Lefty that is only made in human embryonic stem cells (hESCs) suppresses the growth of melanoma and breast cancer cells. They also noted an increase in deaths of the killer cells. The hESC environment might make it possible to develop new cancer therapies.
Of course, the Bush administration and its allies prefer to wait out the clock in order to take the stem cell issue, which polls badly for them, off the table. Will the White House domestic policy council, which appears only to recognize science that vindicates their policy preferences, comment on the Northwestern teams’ result? We can live in hope.
Comments on this article